Clinical Trials Industry News More

  1. Goodwin Biotechnology Inc. Completes cGMP Manufacturing Of AREVA Med's Conjugate 9/15/2009
    Goodwin Biotechnology Inc. (GBI) announced recently the completion of the cGMP manufacturing and vialing of AREVA Med’s monoclonal antibody-chelator conjugate.
  2. NIAID Launches 2009 H1N1 Influenza Vaccine Trial In Pregnant Women 9/14/2009
    The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant women is launching this week, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced recently.
  3. Novel Technique Enables Rapid Size Determination Of Quantum Dots And Nanoparticles 9/10/2009
    Paraytec Ltd. has announced a new application note that demonstrates how its ActiPix HT Nano-Sizing System has been used to rapidly determine the hydrodynamic radius of a series of quantum dot and nanoparticle samples.
  4. Osiris Therapeutics Announces Preliminary Results For Prochymal Phase III GvHD Trials 9/8/2009
    Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced preliminary results for two phase III trials evaluating Prochymal for the treatment of acute graft versus host disease (GvHD). GvHD, the most common complication of bone marrow transplantation, is a life-threatening disease for which there is currently no approved treatment.
  5. Millipore Presents: Innovations And Challenges For Sterilizing-Grade Technologies 9/8/2009
    September 24th Open House Event Recognizes Millipore’s 30 Years of Sterility Assurance
  6. SynCo Bio Partners Enters The Japanese Market As It Signs Its First Agreement With A Japanese Pharmaceutical Company 9/2/2009
    SynCo Bio Partners B.V., the expert in long term GMP contract manufacturing of biopharmaceuticals announced recently that it has expanded its business into a new geographical market, with the signing of a contract to manufacture a live biotherapeutic for an emerging Japanese pharmaceutical company.
  7. XSpray Launches GMP Production Facility 9/1/2009
    XSpray Microparticles AB, the Swedish life science technology company, today announced the launch of its new GMP production facility in Malmö, Sweden.
  8. Merck CEO Announces Structure And Global Leadership Team For New Merck 9/1/2009
    Richard T. Clark, chairman, president and chief executive officer of Merck & Co., Inc. recently announced a new organizational structure and named top management and senior leaders for the new Merck effective upon completion of the merger of Merck & Co., Inc. and Schering-Plough Corporation. Mr. Clark was named CEO of the combined company when the merger agreement was signed in March.
  9. FDA Commissioner Margaret Hamburg, Bestselling Author Jim Collins To Keynote RAPS Annual Conference In Philadelphia 8/31/2009
    Professionals concerned with developing and bringing safe and effective drugs, medical devices, biotechnology and other healthcare products to the worldwide market will convene in Philadelphia next month for the Regulatory Affairs Professionals Society’s (RAPS) 2009 Annual Conference & Exhibition.
  10. Researchers Use Golden Nanotubes For Imaging Agent To Detect Tumor Cells, Map Sentinel Lymph Node 8/31/2009
    Biomedical researchers at the University of Arkansas for Medical Sciences in Little Rock have developed a special contrast-imaging agent that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.